Holen Sie sich die Stockscreener-App
1.66
1.19%
-0.02
Handel nachbörslich:
1.68
0.02
+1.20%
Inovio Pharmaceuticals Inc Aktie (INO) Neueste Nachrichten
Inovio cut 16% of workforce over the past year as FDA decision looms on drug application - The Business Journals
Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) - GlobeNewswire
Inovio Pharmaceuticals, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:INO) 2026-03-13 - Seeking Alpha
Inovio Stock Up On Earnings, Pipeline Progress - Benzinga
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Inovio: Q4 Earnings Snapshot - theheraldreview.com
Inovio Pharmaceuticals Inc (INO) Q4 2025 Earnings Call Highlight - GuruFocus
Inovio Pharmaceuticals (INO) Advances BLA Review for INO-3107 - GuruFocus
Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - lelezard.com
Inovio Pharmaceuticals Q4 Earnings Call Highlights - Yahoo Finance
INO: INO-3107 BLA under FDA review; cash runway extended into Q4 2026 amid focused pipeline progress - TradingView
Earnings call transcript: Inovio Pharmaceuticals’ Q4 2025 results highlight cost reductions - Investing.com
Inovio: Fourth Quarter Earnings Overview - Bitget
INO Advances INO-3107 Amid Financial Adjustments - GuruFocus
Inovio, Akeso partner on Phase 2 trial of new immunotherapy for glioblastoma - Rare Cancer News
INOVIO Pharmaceuticals reveals Q4 and full-year 2025 results amid operational shifts - Traders Union
INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - PR Newswire
Inovio (NASDAQ: INO) details DNA medicine pipeline, INO-3107 FDA review and cash risk - Stock Titan
Bronstein, Gewirtz & Grossman LLC Urges Inovio - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain OfficersINO - ChartMill
INOVIO and Akeso Partner to Study New Glioblastoma Therapy - MyChesCo
INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 - The Malaysian Reserve
Inovio Pharmaceuticals (INO) Set to Announce Q4 Earnings - GuruFocus
Lawsuit Notice: Investors who lost money with shares of Inovio - openPR.com
Risk Off: Is Inovio Pharmaceuticals Inc a momentum stockBond Market & Weekly Momentum Picks - baoquankhu1.vn
INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Ph - GuruFocus
DEADLINE ALERT for TCPC, ORCL, PSFE, and INO: The Law - GlobeNewswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionINO - ACCESS Newswire
Inovio at The Citizens Life Sciences Conference: Strategic Insights on INO-3107 - Investing.com
INO: INO-3107 shows strong efficacy for RRP, with FDA review and commercial launch preparations underway - TradingView
Inovio Pharmaceuticals, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your RightsINO - PR Newswire
2026-03-10 | INO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:INO | Press Release - Stockhouse
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PomDoctor and Inovio and Encourages Investors to Contact the Firm - lincolnjournal.com
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PomDoctor and Inovio and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Levi & Korsinsky, LLP: Chronology of Events in the Inovio Pharmaceuticals Securities Class ... - Bluefield Daily Telegraph
Levi & Korsinsky, LLP: Chronology of Events in the Inovio Pharmaceuticals Securities Class Action - GlobeNewswire
ROSEN, A LEADING AND RANKED FIRM, Encourages Inovio - GlobeNewswire
Inovio Pharmaceuticals, Inc. (GBM.F) Fundamental Analysis - Meyka
Portnoy Law Firm Announces Class Action on Behalf of Inovio Pharmaceuticals, Inc. Investors - GlobeNewswire
INOVIO to share DNA medicine data on HPV surgical interventions and COVID - Stock Titan
2026-03-09 | INO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! | NDAQ:INO | Press Release - Stockhouse
INOVIO to Participate in Upcoming Scientific Conferences - The Malaysian Reserve
2026-03-08 | INO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! | NDAQ:INO | Press Release - Stockhouse
Inovio Pharmaceuticals (INO) Expected to Announce Earnings on Thursday - MarketBeat
ROSEN, A LEADING LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, A LEADING LAW FIRM, Encourages Inovio - GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ramaco Resources, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Inovio Pharmaceuticals, Inc. Sued for Securities Law - GlobeNewswire
INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026 - Barchart.com
INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 - BioSpace
Robbins LLP Urges INO Stockholders Who Lost Money Investing in Inovio Pharmaceuticals, Inc. to ... - Caledonian Record
Robbins LLP Urges INO Stockholders Who Lost Money Investing - GlobeNewswire
INO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
2026-03-05 | INO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! | NDAQ:INO | Press Release - Stockhouse
INOVIO sets March 12 call to review 2025 results and analyst Q&A - Stock Titan
Inovio, Akeso announce clinical collaboration - TipRanks
Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire
LEVI & KORSINSKY, LLP: INO SHARES DECLINE 24% AS FDA REVIEW CLAS - GuruFocus
UPCOMING DEADLINE: Inovio Pharmaceuticals (INO) Securities - GlobeNewswire
LEVI & KORSINSKY, LLP: INO SHARES DECLINE 24% AS FDA REVIEW CLASSIFICATION REVEALS ALLEGED REGULATORY SETBACK - Finviz
LEVI & KORSINSKY, LLP: INO SHARES DECLINE 24% AS FDA REVIEW CLASSIFICATION REVEALS ALLEGED REGULATORY SETBACK (2026-03-04) - Seeking Alpha
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):